Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 421–435 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5988
GALNS Gene Mucopolysaccharidosis Type IVA Genetic Test

This genetic test sequences the GALNS gene to identify pathogenic variants associated with Mucopolysaccharidosis Type IVA (Morquio A Syndrome). It provides a definitive molecular d...

Peripheral Whole Blood (EDTA), FTA Card, or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GALNS gene", "Copy Number Variations (CNV) in the GALNS gene"]
Parameters
[]
Preparation
["A detailed clinical history of the patient is mandatory.", "A genetic counselling session must be undertaken to draw a pedigree chart."]
Indications
["Clinical suspicion of Mucopolysaccharidosis Type IVA (Morquio A Syndrome)", "Carrier screening for family planning", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83365-7 ICD-10: E76.2
Clinical summary
This genetic test sequences the GALNS gene to identify pathogenic variants associated with Mucopolysaccharidosis Type IVA (Morquio A Syndrome). It provides a definitive molecular diagnosis for affected individuals.
TEST-5831
GALNT3 Gene Genetic Test for Tumoral Calcinosis, Hyperphosphatemic, Familial, Type 1

This test identifies mutations within the GALNT3 gene associated with hyperphosphatemic familial tumoral calcinosis type 1.

Whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GALNT3 gene sequence", "Copy number variations in GALNT3"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed phosphate-lowering medications"]
Indications
["Diagnosis of hyperphosphatemic familial tumoral calcinosis type 1", "Carrier screening", "Family testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82443-0 ICD-10: E83.51, E83.59
Clinical summary
This test identifies mutations within the GALNT3 gene associated with hyperphosphatemic familial tumoral calcinosis type 1.
TEST-6315
GALT Gene Galactosemia Genetic Test

This test detects pathogenic variants in the GALT gene associated with classic galactosemia.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GALT gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected classic galactosemia", "Family history of galactosemia", "Newborn screening positive for galactosemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94831-3 ICD-10: E74.21
Clinical summary
This test detects pathogenic variants in the GALT gene associated with classic galactosemia.
TEST-6252
GAMT Gene (Guanidinoacetate Methyltransferase Deficiency) Next‑Generation Sequencing Genetic Test

This genetic test evaluates the GAMT gene for mutations causing guanidinoacetate methyltransferase deficiency.

Whole blood (EDTA) or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)", "GAMT gene sequence"]
Parameters
[]
Preparation
["No specific fasting required", "No need to stop prescribed medications unless advised by a physician"]
Indications
["Confirmation of suspected guanidinoacetate methyltransferase deficiency", "Carrier screening in families with known GAMT mutations", "Family screening for at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 84591-3 ICD-10: E72.89, Z13.71, Z31.5
Clinical summary
This genetic test evaluates the GAMT gene for mutations causing guanidinoacetate methyltransferase deficiency.
TEST-4520
GAN Gene (Giant Axonal Neuropathy Type 1) Genetic Test

This genetic test analyzes the GAN gene for pathogenic variants associated with Giant Axonal Neuropathy type 1.

Whole Blood (EDTA) or Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GAN gene", "Biallelic or monoallelic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any anticoagulation medication"]
Indications
["Suspected diagnosis of Giant Axonal Neuropathy type 1", "Family history of GAN1", "Differential diagnosis of progressive neurological disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82810-3 ICD-10: G60.8
Clinical summary
This genetic test analyzes the GAN gene for pathogenic variants associated with Giant Axonal Neuropathy type 1.
TEST-3354
GATA1 Gene Anemia, X-linked Genetic Test

This test evaluates the GATA1 gene for pathogenic variants associated with X-linked dyserythropoietic anemia and thrombocytopenia.

Peripheral Whole Blood (2–5 mL) or FTA Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GATA1 gene", "Coding regions and splice sites"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (complete coding region coverage)"}]
Preparation
["Genetic counseling is mandatory prior to sample collection.", "Do not discontinue prescribed medications without consulting your treating physician."]
Indications
["Diagnostic confirmation of X-linked dyserythropoietic anemia", "Family cascade screening", "Guiding clinical management of hematologic manifestations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51594-0 ICD-10: D64.8
Clinical summary
This test evaluates the GATA1 gene for pathogenic variants associated with X-linked dyserythropoietic anemia and thrombocytopenia.
TEST-4130
GATA4 Gene Tetralogy of Fallot Genetic Test

This test detects pathogenic variants in the GATA4 gene associated with Tetralogy of Fallot.

Whole Blood (Peripheral) 21 – 28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["GATA4 gene pathogenic variants", "Point mutations", "Small indels", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Confirmation of Tetralogy of Fallot diagnosis", "Assessment of familial recurrence risk", "Guidance for lifelong cardiac surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94083-3 ICD-10: Q21.3
Clinical summary
This test detects pathogenic variants in the GATA4 gene associated with Tetralogy of Fallot.
TEST-4397
GATA6 Gene Atrioventricular Septal Defect Type 5 NGS Test

This test identifies genetic variants in the GATA6 gene associated with atrioventricular septal defect type 5 (AVSD5). It uses next-generation sequencing (NGS) for comprehensive an...

Whole blood (EDTA), extracted DNA, dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs) in GATA6 gene", "Insertions/deletions (indels) in GATA6 gene", "Copy number changes in GATA6 gene"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis confirmation of AVSD type 5", "Assessment of recurrence risk in families", "Guidance for surgical planning", "Identification of underlying genetic cause"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21561-4 ICD-10: Q21.2
Clinical summary
This test identifies genetic variants in the GATA6 gene associated with atrioventricular septal defect type 5 (AVSD5). It uses next-generation sequencing (NGS) for comprehensive analysis.
TEST-4916
GATAD2B Gene Sequencing (Autosomal Dominant Intellectual Disability Type 18) NGS Test

This diagnostic test evaluates the GATAD2B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 18 (MRD18).

Peripheral Whole Blood (EDTA tube) or Dried Blood Spot (FTA Card) 21 to 28 Days (3–4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["GATAD2B gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Small Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Suspected Autosomal Dominant Intellectual Disability Type 18 (MRD18)", "Unexplained intellectual disability with relevant clinical features", "Family history of MRD18"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94474-7 ICD-10: Q87.89
Clinical summary
This diagnostic test evaluates the GATAD2B gene for pathogenic variants associated with Autosomal Dominant Intellectual Disability Type 18 (MRD18).
TEST-6112
GATM Gene (Arginine:Glycine Amidinotransferase [AGAT] Deficiency) Genetic Test

This test identifies pathogenic variants in the GATM gene responsible for arginine:glycine amidinotransferase (AGAT) deficiency.

Peripheral whole blood (3–5 mL EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GATM gene", "Full gene coverage including exons, splice sites, and regulatory regions"]
Parameters
[]
Preparation
["No fasting required", "Avoid recent blood transfusions (within 2 weeks)", "Avoid use of certain anti-metabolites or creatine supplements (consult genetic counsellor for washout guidance)"]
Indications
["Suspected AGAT deficiency based on clinical presentation", "Confirmation of diagnosis in individuals with biochemical abnormalities (e.g., elevated guanidinoacetate)", "Family screening for carriers or affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50398-7 ICD-10: E72.8
Clinical summary
This test identifies pathogenic variants in the GATM gene responsible for arginine:glycine amidinotransferase (AGAT) deficiency.
TEST-1330
Gaucher Disease Quantitative Blood Test

This diagnostic test evaluates the activity level of the glucocerebrosidase enzyme in peripheral whole blood.

Peripheral whole blood (venous draw) 4 Calendar Days (sample by 4 pm daily) 550.00 AED
View
View test specifications and preparation
What it measures
["Glucocerebrosidase enzyme activity", "Lysosomal storage disorder marker"]
Parameters
[{"name": "Glucocerebrosidase Enzyme Activity", "reference_range": null}]
Preparation
["Maintain normal hydration.", "Avoid aspirin or NSAIDs for 48 hours before collection.", "Inform phlebotomist about anticoagulant therapy."]
Indications
["Diagnosis of Gaucher disease", "Assessment of Gaucher disease severity", "Monitoring response to therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48173-2 ICD-10: E75.22
Clinical summary
This diagnostic test evaluates the activity level of the glucocerebrosidase enzyme in peripheral whole blood.
TEST-6091
GBE1 Gene (Andersen Disease) Genetic Test

This genetic test identifies pathogenic variants in the GBE1 gene associated with Andersen disease (glycogen storage disease type IV).

Whole Blood (EDTA), Extracted DNA, or FTA Card Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GBE1 gene", "Presence of mutations causing Andersen disease"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications being taken"]
Indications
["Suspected Andersen disease based on clinical presentation", "Family history of glycogen storage disease type IV", "Carrier screening in relatives of affected individuals", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: E74.09, Z15.89, Z13.228
Clinical summary
This genetic test identifies pathogenic variants in the GBE1 gene associated with Andersen disease (glycogen storage disease type IV).
TEST-6338
GBE1 Gene Glycogen Storage Disease Type IV Genetic Test

This test identifies pathogenic mutations in the GBE1 gene, confirming a diagnosis of Glycogen Storage Disease Type IV (Andersen disease).

Whole blood (EDTA) or FTA card 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GBE1 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"]
Parameters
[]
Preparation
["Mandatory genetic counselling session required.", "No fasting required unless otherwise instructed.", "Continue prescribed medications unless advised otherwise by a doctor.", "Disclose any recent blood transfusions."]
Indications
["Suspected Glycogen Storage Disease Type IV (Andersen disease)", "Confirmatory diagnosis", "Family screening for GSD IV", "Early intervention planning", "Proactive management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50397-9 ICD-10: E74.09
Clinical summary
This test identifies pathogenic mutations in the GBE1 gene, confirming a diagnosis of Glycogen Storage Disease Type IV (Andersen disease).
TEST-3754
GFAP Gene Alexander Disease Genetic Test

This test evaluates the entire GFAP gene for mutations associated with Alexander disease.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No medication changes necessary unless instructed"]
Indications
["Clinical suspicion of Alexander disease", "Family history of Alexander disease", "Infantile macrocephaly with progressive spasticity and ataxia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92550-1 ICD-10: G31.89
Clinical summary
This test evaluates the entire GFAP gene for mutations associated with Alexander disease.
TEST-6223
GFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 1 Genetic Test

This genetic test identifies disease-causing variants in the GFM1 gene associated with combined oxidative phosphorylation deficiency type 1.

Peripheral Whole Blood (EDTA) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GFM1 gene", "Single-nucleotide variants", "Copy-number variants"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of combined oxidative phosphorylation deficiency type 1", "Carrier screening in at-risk families", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101447-4 ICD-10: E88.49
Clinical summary
This genetic test identifies disease-causing variants in the GFM1 gene associated with combined oxidative phosphorylation deficiency type 1.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area